This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Kristin Baldwin | |
|---|---|
| Name | Kristin Baldwin |
| Fields | Cell biology; Neuroscience; Stem cell biology |
| Workplaces | Johns Hopkins University School of Medicine; National Institutes of Health |
| Alma mater | Northwestern University; Duke University |
| Known for | Human neuronal differentiation; Induced pluripotent stem cell models; CRISPR functional genomics |
Kristin Baldwin is an American cell biologist and neuroscientist known for contributions to human neuronal differentiation, induced pluripotent stem cell (iPSC) modeling, and functional genomics. She leads a translational research group that integrates stem cell technologies, gene editing, and high-throughput screening to model neurodegenerative and neurodevelopmental disorders. Her work bridges basic science, translational medicine, and collaborative consortia involving academic medical centers and funding agencies.
Baldwin completed undergraduate studies at Northwestern University where she studied subjects related to cell and molecular biology and participated in laboratory research connected to clinical programs at affiliated hospitals. She earned her doctoral training and postdoctoral work at institutions including Duke University and research programs associated with the National Institutes of Health, gaining expertise in neuronal development, stem cell biology, and genetic engineering techniques such as CRISPR and viral vector methods. During early training she collaborated with investigators at university medical centers and national research institutes, engaging with cohorts focused on translational neuroscience and genetics.
Baldwin has held faculty appointments at the Johns Hopkins University School of Medicine and has been affiliated with translational research programs that partner with industry consortia and governmental funding bodies. Her laboratory developed platforms for differentiation of human pluripotent stem cells into defined neuronal subtypes for disease modeling used by collaborative networks including academic cores, biotechnology companies, and nonprofit research foundations. Baldwin’s group integrates methods from developmental neurobiology, functional genomics, and high-content imaging, and participates in collaborative initiatives with clinical departments, core facilities, and regulatory science stakeholders.
Baldwin’s research established approaches for direct differentiation of human induced pluripotent stem cells into functional neuronal populations and for using iPSC-derived neurons in large-scale genetic and pharmacologic screens. Her team applied CRISPR-based perturbation and pooled screening strategies to identify genes and pathways modulating neuronal survival, axon maintenance, and synaptic function, informing studies of disorders such as Amyotrophic lateral sclerosis, Parkinson's disease, and inherited peripheral neuropathies. Baldwin contributed to demonstrations that patient-derived iPSCs capture disease-relevant phenotypes and can be used to prioritize therapeutic targets validated through in vitro assays and orthogonal models including rodent primary neurons and organoid systems. Her group also advanced protocols for generating specific neuronal subtypes relevant to motor neuron disease, sensory neuropathy, and cortical dysfunction, and integrated transcriptomic profiling tools such as single-cell RNA-sequencing and bulk RNA-seq to map differentiation trajectories and disease-associated signatures. Collaborations with clinical genetics teams and large-scale sequencing consortia helped translate variant interpretation findings into functional evidence used by diagnostic and clinical research programs.
Baldwin’s work has been recognized by awards and honors from academic societies, translational research organizations, and funding bodies that support stem cell and neuroscience research. She has received competitive grants from national funding agencies and philanthropic foundations that support neurodegeneration research, and has been invited to present keynote and plenary talks at meetings organized by societies focused on neuroscience, stem cell research, and genomics. Her laboratory’s contributions are cited in multi-investigator consortia publications and translational program announcements from major biomedical institutes.
- Baldwin KA et al., studies on iPSC-derived neuronal differentiation and modeling of neurodegenerative phenotypes published in peer-reviewed journals in collaboration with researchers from university medical centers, national research institutes, and specialty societies. - Baldwin K et al., reports describing CRISPR-based functional genomic screens in human neurons and identification of modifiers of neuronal survival and axon degeneration. - Baldwin K et al., protocols and methodological papers on generation of neuronal subtypes from human pluripotent stem cells and application to disease modeling and drug screening.
Baldwin participates in interdisciplinary education and outreach programs linking academic research, patient advocacy groups, and public engagement initiatives. She collaborates with clinical teams, patient organizations, and nonprofit advocacy networks to translate laboratory findings into resources useful for clinicians, genetic counselors, and families affected by neurologic disorders. Baldwin contributes to training programs for graduate students and postdoctoral fellows and serves on advisory panels and review committees for research funding organizations.
Category:American neuroscientists Category:Stem cell researchers